ScripWith Roche Holding AG 's new wet age-related macular degeneration (AMD) and diabetic eye disease drug Vabysmo (faricimab) off to an impressive early commercial launch, the company showcased the eye d
In VivoBiopharma Acquisitions Biopharma merger and acquisition value for the third quarter of 2022 reached $15.4bn from 41 transactions, 21 of which had disclosed values. Four M&A transactions hit or exceede